bluebird bio, Inc. Common Stock, par value $0.01 per share Having an Aggregate Offering Price of up to Equity Distribution AgreementTerms Agreement • June 22nd, 2022 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • New York
bluebird bio, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Goldman Sachs & Co. LLC (the “Manager”) as follows:
